Vaccines Europe - 20 May 2020
Vaccine procurement processes differ across EU Member States, however, national/regional procurement through tenders is most often used. Vaccines provide great value for people and society at large.
Unfortunately, tendering practices do not always reflect the value of the vaccines and often tender processes insufficiently consider the length and complexity of vaccines manufacturing, the increasing global demand for existing and novel vaccines, or the limitations of the small base of manufacturers able to provide high-quality vaccines.
This paper outlines recommendations on national/regional public tender practices in the EU and calls for EU Guidelines on vaccine procurement, to improve timely and consistent availability of vaccines for EU citizens and citizens of the world.
Find the Vaccines Europe’s Paper on “Recommendations to improve tendering practices of vaccines in EU Member States” here.